Arlington biotech company names CFO

Mike Cadigan joins Kerecis

Published January 25, 2021 by Sydney Lake

Regenerative tissue producer Kerecis, which has its U.S. headquarters in Arlington, announced last week it has named Mike Cadigan as its chief financial officer.

With 25 years of experience, Cadigan was most recently the managing partner of Cadigan Capital, where he previously advised Kerecis since 2017. Kerecis was founded in Iceland in 2013 and established its U.S. headquarters in 2016.

“Mike has extensive experience in corporate finance, development and investment banking for both emerging and mature companies,” Kerecis founder and CEO G. Fertram Sigurjonsson said in a statement. “His leadership and insight will be invaluable as we accelerate our growth and drive our business to the next level.”

Cadigan will oversee the company’s finances and lead corporate development activities.

“I am drawn to the Kerecis vision for improving health outcomes for its patients and its embrace of sustainability,” Cadigan said in a statement. “Its value-from-waste position saves lives and generates revenue with products that are kind to the environment.”

Cadigan earned his bachelor’s degree in economics and his master’s degree in business administration from the University of California, Irvine.

The company uses fish skin and fatty acids to create cellular therapy and regenerative tissue products. In 2019, Kerecis acquired Swiss life-science company Phytoceuticals AG, which has since changed its name to Kerecis AG.